GeneTouch Corporation reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 190.92 million compared to TWD 282.59 million a year ago. Net loss was TWD 68.17 million compared to net income of TWD 0.59 million a year ago.

Basic loss per share from continuing operations was TWD 3.76 compared to basic earnings per share from continuing operations of TWD 0.04 a year ago. Diluted loss per share from continuing operations was TWD 3.76 compared to diluted earnings per share from continuing operations of TWD 0.04 a year ago.